Treatment of HIV-associated nephropathy

Seminars in Nephrology

Volumn 20, Issue 3, 2000, Pages 293-298

  Winston, Jonathan A ^a   Burns, Godfrey C ^b   Klotman, Paul E ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; CHRONIC KIDNEY DISEASE; ENZYME INHIBITION; FOLLOW UP; GENE LOCUS; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; SURVIVAL RATE;

AIDS-ASSOCIATED NEPHROPATHY; HUMANS;

EID: 0034040334     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. D'Agati V, Appel GB: HIV infection and the kidney. J Am Soc Nephrol 8:138-152, 1997
2. D'Agati V, Suh JI, Carbone L, et al: Pathology of HIVassociated nephropathy: A detailed morphologie and comparative study. Kidney Int 35:1358-1370, 1989
3. D'Agati V, Appel GB: Renal pathology of human immunodeficiency virus infection. Semin Nephrol 18:406-421, 1998
4. Cohen AH, Nast CC: HIV-associated nephropathy. A unique combined glomerular, tubular, and interstitial lesion. Mod Pathol 1:87-97, 1988
5. Cantor ES, Kimmel PL, Bosch JP: Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch Intern Med 151:125-128, 1991
6. Carbone L, D'Agati V, Cheng JT, et al: Course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87:389-395, 1989
7. Bourgoignie JJ, Pardo V: HIV-associated nephropathies. N Engl J Med 327:729-730, 1992
8. Humphreys MH: Human immunodeficiency virus-associated glomerulosclerosis. Kidney Int 48:311-320, 1995
9. Rao TK: Clinical features of human immunodeficiency virus associated nephropathy. Kidney Int 35:S13-S18, 1991 (suppl)
10. Rao TK: Human immunodeficiency virus (HIV) associated nephropathy. Annu Rev Med 42:391-401, 1991
11. Poli A, Abramo F, Matteucci D, et al: Renal involvement in feline immunodeficiency virus infection: p24 antigen detection, virus isolation and PCR analysis. Vet Immunol Immunopathol 46:13-20, 1995
12. Poli A, Abramo F, Taccini E, et al: Renal involvement in feline immunodeficiency virus infection: A clinicopathological study. Nephron 64:282-288, 1993
13. Stephens EB, Tian C, Li Z, et al: Rhesus macaques infected with macrophage-tropic simian immunodeficiency virus (SIVmacR71/17E) exhibit extensive focal segmental and global glomerulosclerosis. J Virol 72:8820-8832, 1998
14. Kopp JB, Klotman ME, Adler SH, et al: Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes. Proc Natl Acad Sei U S A 89:1577-1581, 1992
15. Klotman PE, Notkins AL: Transgenic models of human immunodeficiency virus type-1. Curr Top Microbiol Immunol 206:197-222, 1996
16. Winston JA, Klotman PE: Are we missing an epidemic of HIV-associated nephropathy? J Am Soc Nephrol 7:1 -7,1996
17. Praditpornsilpa K, Napathorn S, Yenrudi S, et al: Renal pathology and HIV infection in Thailand. Am J Kidney Dis 33:282-286, 1999
18. Nochy D, Glotz D, Dosquet P, et al: Renal disease associated with HIV infection: A multicentric study of 60 patients from Paris hospitals. Nephrol Dial Transplant 8:11-19, 1993
19. Casanova S, Mazzucco G, Barbiano de Belgiojoso G, et al: Pattern of glomerular involvement in human immunodeficiency virus-infected patients: An Italian study. Am J Kidney Dis 26:446-453, 1995
20. Winston JA, Burns GC, Klotman PE: The human immunodeficiency virus (HIV) epidemic and HIV-associated nephropathy. Semin Nephrol 18:373-377, 1998
21. Centers for Disease Control and Prevention, HIV/AIDS Surveillance Report II (No. 1), 1999
22. US Renal Data System: USRDS 1999 annual data report. Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1999
23. Klotman PE: HIV-associated nephropathy [clinical conference]. Kidney Int 56:1161-1176, 1999
24. Schwanz EJ, Klotman PE: Pathogenesis of human immunodeficiency virus (HlV)-associated nephropathy. Semin Nephrol 18:436-445, 1998
25. Freedman BI, Soucie JM, Stone SM, et al: Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am J Kidney Dis 34:254-258, 1999
26. Smith MW, Dean M, Carrington M, et al: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science 277: 959-965, 1997
27. Kimmel PL, Bosch JP, Vassalotti JA: Treatment of human immunodeficiency virus (HlV)-associated nephropathy. Semin Nephrol 18:446-458, 1998
28. Klotman PE, Rappaport J, Ray P, et al: Transgenic models of HIV-1. Aids 9:313-324, 1995
29. Gharavi A, Oiler S, Bruggeman L, et al: Genetic background modifies the development of renal disease in HIV-1 transgenic mice. J Amer Soc Nephrol 10:404A, 1999 (abstr)
30. Smith SR, Svetky LP, Dennis VW: Racial differences in the incidence and progression of renal disease. Kidney Int 40:815-822, 1991
31. Ray PE, Liu XH, Henry D, et al: Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy. Kidney Int 53:1217-1219, 1998
32. Singhal PC, Sharma P, Loona R, et al: Enhanced proliferation, apoptosis, and matrix accumulation by mesangial cells derived from HIV-1 transgenic mice. J Investig Med 46:297-302, 1998
33. Barisoni L, Kriz W, Mundel P, et al: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51-61, 1999
34. Yamamoto T, Noble NA, Miller DE, et al: Increased levels of transforming growth factor-beta in HIV-associated nephropathy. Kidney Int 55:579-592, 1999
35. Shukla RR, Kumar A, Kimmel PL: Transforming growth factor beta increases the expression of HIV-1 gene in transfected human mesangial cells. Kidney Int 44:1022-1029, 1993
36. Ray PE, Bruggeman LA, Weeks BS, et al: bFGF and its low affinity receptors in the pathogenesis of HIV-associated nephropathy in transgenic mice. Kidney Int 46:759-772, 1994
37. Winston JA, Klotman ME, Klotman PE: HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int 55:1036-1040, 1999
38. Laradi A, Mallet A, Beaufils H, et al: HIV-associated nephropathy: Outcome and prognosis factors. Groupe d'Etudes Nephrologiques d'Ile de France. J Am Soc Nephrol 9:2327-2335, 1998
39. Kimmel PL, Mishkin GJ, Umana WO: Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am J Kidney Dis 28:202-208, 1996
40. Kimmel PL, Phillips TM, Ferreira-Centeno A, et al: HIV-associated immune-mediated renal disease. Kidney Int 44:1327-1340, 1993
41. Kimmel PL, Phillips TM, Ferreira-Centeno A, et al: Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 327:702-706, 1992
42. Stokes MB, Chawla H, Brody RI, et al: Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus. Am J Kidney Dis 29: 514-525, 1997
43. Cheng JT, Anderson, Jr. HL, Markowitz GS, et al: Hepatitis C virus-associated glomerular disease in patients with human immunodeficiency virus coinfection. J Am Soc Nephrol 10:1566-1574, 1999
44. Eitner F, Cui Y, Hudkins KL, et al: Thrombotic microangiopathy in the HIV-2-infected macaque. Am J Pathol 155:649661, 1999
45. Centers for Disease Control and Prevention: Report of the NIH Panel to Define Principles of Therapy of HIV Infection and Guidelines for the Use of Antiretroviral Agents in HIVInfected Adults and Adolescents. MMWR 47(No. RR-5), 1998
46. Gurtman A, Borrego F, Klotman ME: Management of antiretroviral therapy. Semin Nephrol 18:459-480, 1998
47. Ifudu O, Rao TK, Tan CC, et al: Zidovudine is beneficial in human immunodeficiency virus associated nephropathy. Am J Nephrol 15:217-221, 1995
48. Michel C, Dosquet P, Ronco P, et al: Nephropathy associated with infection by human immunodeficiency virus: A report on 11 cases including 6 treated with zidovudine. Nephron 62:434-440, 1992
49. Wali RK, Drachenberg CI, Papadimitriou JC, et al: HIV1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet 352:783-784, 1998
50. Szcech LA, van der Horst C, Bartlett JA, et al: Protease inhibitors are associated with a slowed progression HIV-associated nephropathy. J Amer Soc Neph 10:116A, 1999 (abstr)
51. Centers for Disease Control: Update: Trends in AIDS Incidence-United States, 1996. MMWR 46(No. 37), 1997
52. Appel RG, Neill J: A steroid-responsive nephrotic syndrome in a patient with human immunodeficiency virus (HIV) infection. Ann Intern Med 113:892-893, 1990
53. Briggs WA, Tanawattanacharoen S, Choi MJ, et al: Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 28:618-621, 1996
54. Watterson MK, Detwiler RK, Bolin, Jr. P: Clinical response to prolonged corticosteroids in a patient with human immunodeficiency virus-associated nephropathy. Am J Kidney Dis 29:624-626, 1997
55. Smith MC, Pawar R, Carey JT, et al: Effect of corticosteroid therapy on human immunodeficiency virus-associated nephropathy. Am J Med 97:145-151, 1994
56. Smith MC, Austen JL, Carey JT, et al: Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med 101:41-48, 1996
57. Ruggenenti P, Pema A, Gherardi G, et al: Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352:1252-1256, 1998
58. Ruggenenti P, Perna A, Gherardi G, et al: Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet 354:359-364, 1999
59. Lewis EJ, Hunsicker LG, Bain RP, et al: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group (published erratum appears in N Engl J Med 330:152, 1993) N Engl J Med 329:1456-1562, 1993
60. Burns GC, Paul SK, Toth IR, et al: Effect of angiotensinconverting enzyme inhibition in HIV-associated nephropathy. J Am Soc Nephrol 8:1140-1146, 1997
61. Burns GC, Visintainer P, Mohammed NB: Effect of angiotensin converting-enzyme inhibition on progression of renal disease and mortality in HIV-associated nephropathy. J Amer Soc Nephrol 10:155A, 1999 (abstr)
62. Bird JE, Durham SK, Giancarli MR, et al: Captopril prevents nephropathy in HIV-transgenic mice. J Am Soc Nephrol 9:1441-1447, 1998
63. Ahuja T, Memon A, Bhalli S, et al: Highly active antiretroviral therapy improves survival of HIV-infected hemodialysis patients. J Amer Soc Nephrol 10:260A, 1999 (abstr)
64. Ifudu O, Mayers JD, Matthew JJ, et al: Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: Has the outcome changed in the 1990s? Am J Kidney Dis 29:549-552, 1997